AVITA Medical, Inc. (RCEL) Operating Expenses (2018 - 2026)

AVITA Medical (RCEL) has reported Operating Expenses for 9 consecutive years, with $24.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 5.65% year-over-year to $24.6 million; the trailing twelve-month figure through Jun 2026 stood at $98.5 million (down 10.36% YoY), and the FY2025 full-year result was $101.4 million, down 9.31% from the prior year.
• Operating Expenses was little changed at $24.6 million in Q2 2026 per RCEL's latest filing, from $24.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $30.2 million in Q3 2024 and bottomed at $14.2 million in Q3 2022.
• Historically, Operating Expenses has averaged $23.2 million across 5 years, with a median of $24.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses slumped 63.39% in 2022, then surged 48.09% in 2023.
• Over 5 years, Operating Expenses stood at $17.6 million in 2022, then jumped by 40.6% to $24.7 million in 2023, then gained by 5.47% to $26.1 million in 2024, then fell by 5.23% to $24.7 million in 2025, then retreated by 0.39% to $24.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $24.6 million, $24.7 million, and $23.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.